|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.79(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,005,861 |
52
Week Range: |
$38.26 - $88.63 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bryant Douglas C |
President & CEO |
|
2017-06-29 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
296,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-06-28 |
4 |
S |
$27.35 |
$328,200 |
D/D |
(12,000) |
284,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-06-28 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
296,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-05-31 |
4 |
S |
$24.93 |
$299,160 |
D/D |
(12,000) |
284,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-05-31 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
296,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-05-30 |
4 |
S |
$25.10 |
$301,200 |
D/D |
(12,000) |
284,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-05-30 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
296,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-05-26 |
4 |
S |
$24.90 |
$298,800 |
D/D |
(12,000) |
284,493 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2017-05-26 |
4 |
OE |
$12.36 |
$148,320 |
D/D |
12,000 |
296,493 |
|
- |
|
Slacik Charles P |
Director |
|
2017-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
2,601 |
|
- |
|
Widder Kenneth J |
Director |
|
2017-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
6,210 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2017-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
13,012 |
|
- |
|
Buechler Kenneth F |
Director |
|
2017-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,263 |
22,418 |
|
- |
|
Slacik Charles P |
Director |
|
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,111 |
1,639 |
|
- |
|
Widder Kenneth J |
Director |
|
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,022 |
5,248 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,618 |
12,050 |
|
- |
|
Brown Thomas D |
Director |
|
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,022 |
44,063 |
|
- |
|
Buechler Kenneth F |
Director |
|
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,725 |
21,155 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2017-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,101 |
10,432 |
|
- |
|
Widder Kenneth J |
Director |
|
2017-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,107 |
3,226 |
|
- |
|
Buechler Kenneth F |
Director |
|
2017-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,315 |
17,430 |
|
- |
|
Brown Thomas D |
Director |
|
2017-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,631 |
42,041 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2017-05-02 |
4 |
S |
$24.50 |
$245,000 |
D/D |
(10,000) |
37,759 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2017-05-02 |
4 |
OE |
$12.63 |
$126,300 |
D/D |
10,000 |
47,759 |
|
- |
|
Bujarski Robert Joseph |
SVP, Bus Dev & Gen Counsel |
|
2017-05-01 |
4 |
S |
$24.19 |
$803,948 |
D/D |
(33,225) |
37,759 |
|
- |
|
1127 Records found
|
|
Page 25 of 46 |
|
|